Medicine & Life Sciences
Urinary Bladder Neoplasms
100%
Carcinoma
79%
Drug Therapy
58%
atezolizumab
51%
Cisplatin
49%
Prostatic Neoplasms
42%
Cystectomy
40%
enfortumab vedotin
39%
Muscles
38%
Platinum
37%
Neoplasms
33%
Survival
30%
Therapeutics
23%
Urinary Bladder
22%
Castration
19%
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea
18%
fibroblast growth factor 13
17%
Nephroureterectomy
17%
cabazitaxel
17%
MDV 3100
15%
Histology
14%
Renal Cell Carcinoma
13%
Androgen Antagonists
13%
pembrolizumab
12%
DNA Repair
12%
Vinblastine
12%
Recurrence
12%
Fibroblast Growth Factor Receptors
11%
Safety
11%
Nectins
11%
Radiotherapy
11%
Mutation
11%
Immunoconjugates
11%
Salvage Therapy
11%
Carcinoma in Situ
11%
Bacillus
10%
Transcriptome
10%
abiraterone
10%
Prostatectomy
10%
Methotrexate
9%
IT-101
9%
apatorsen
9%
Doxorubicin
9%
gemcitabine
8%
Clinical Trials
8%
irofulven
8%
Radium-223
8%
Research Personnel
8%
Patient Care
8%